Obimet GX Forte 2mg Tablet PR is a combination oral hypoglycemic agent containing Glimepiride 2mg and Metformin 1000mg, indicated for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class drug, stimulates pancreatic beta cells to enhance insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, primarily acts by decreasing hepatic glucose production, improving peripheral glucose uptake, and enhancing insulin sensitivity. The synergistic action of these two agents provides effective glycemic control in patients inadequately managed by diet, exercise, or monotherapy. Obimet GX Forte 2mg Tablet PR is typically prescribed when monotherapy with either agent is insufficient to achieve target glycemic goals. The prolonged-release formulation of metformin allows for improved gastrointestinal tolerability and sustained plasma concentration, facilitating once or twice-daily dosing. It is essential to monitor renal function prior to and during therapy due to the risk of lactic acidosis associated with metformin. Common adverse effects include gastrointestinal disturbances such as nausea, vomiting, and diarrhea, as well as hypoglycemia related to glimepiride. This medication should be used under strict medical supervision, with regular monitoring of blood glucose levels and adjustment of dosage based on therapeutic response and tolerability.